A Phase I Study to Determine Safety, Tolerability and Bioactivity of Nexvax2® in HLA DQ2+ Volunteers With Celiac Disease Following a Long-Term, Strict Gluten-Free Diet

✍ Scribed by Brown, Gregor J.; Daveson, James; Marjason, Joanne K.; Ffrench, Rose A.; Smith, Danielle; Sullivan, Mark; Tye-Din, Jason A.; Anderson, Robert P.

• Book ID: 122542671
• Publisher: Elsevier Science
• Year: 2011
• Tongue: English
• Weight: 70 KB
• Volume: 140
• Category: Article
• ISSN: 0016-5085
• DOI: 10.1016/S0016-5085(11)61794-0